As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, a major pharmaceutical company plans to set up a new division dedicated to developing biotherapeutic drugs and research technologies. The company expects to pay $120 million for set up costs of its new division now and $7 million operating costs each year for the next 15 years. The company estimates that the new division will be able to generate annual revenue of $46 million beginning 6 years from now. What is the conventional Benefit-to-Cost ratio for this investment if the company's discount rate is 12 % per year and the project life is 15 years? Answer: